Showing 1 to 10 of 671 records(fetched in 3.245 seconds)
TitleHealth information technology and digital innovation for national learning health and care systems.
AuthorsSheikh, A; Anderson, M; Albala, S; Casadei, B; Franklin, BD; Richards, M; Taylor, D; Tibble, H; Mossialos, E
JournalThe Lancet. Digital health
Publication Date1 Jun 2021
Date Added to PubMed11 May 2021
AbstractHealth information technology can support the development of national learning health and care systems, which can be defined as health and care systems that continuously use data-enabled infrastructure to support policy and planning, public health, and personalisation of care. The COVID-19 pandemic has offered an opportunity to assess how well equipped the UK is to leverage health information technology and apply the principles of a national learning health and care system in response to a major public health shock. With the experience acquired during the pandemic, each country within the UK should now re-evaluate their digital health and care strategies. After leaving the EU, UK countries now need to decide to what extent they wish to engage with European efforts to promote interoperability between electronic health records. Major priorities for strengthening health information technology in the UK include achieving the optimal balance between top-down and bottom-up implementation, improving usability and interoperability, developing capacity for handling, processing, and analysing data, addressing privacy and security concerns, and encouraging digital inclusivity. Current and future opportunities include integrating electronic health records across health and care providers, investing in health data science research, generating real-world data, developing artificial intelligence and robotics, and facilitating public-private partnerships. Many ethical challenges and unintended consequences of implementation of health information technology exist. To address these, there is a need to develop regulatory frameworks for the development, management, and procurement of artificial intelligence and health information technology systems, create public-private partnerships, and ethically and safely apply artificial intelligence in the National Health Service.
Linkhttp://doi.org/10.1016/S2589-7500(21)00005-4
TitleThe Relation Between eHealth Literacy and Health-Related Behaviors: Systematic Review and Meta-analysis.
AuthorsKim, K; Shin, S; Kim, S; Lee, E
JournalJournal of medical Internet research
Publication Date30 Jan 2023
Date Added to PubMed31 Jan 2023
AbstractWith widespread use of the internet and mobile devices, many people have gained improved access to health-related information online for health promotion and disease management. As the health information acquired online can affect health-related behaviors, health care providers need to take into account how each individual's online health literacy (eHealth literacy) can affect health-related behaviors. To determine whether an individual's level of eHealth literacy affects actual health-related behaviors, the correlation between eHealth literacy and health-related behaviors was identified in an integrated manner through a systematic literature review and meta-analysis. The MEDLINE, Embase, Cochrane, KoreaMed, and Research Information Sharing Service databases were systematically searched for studies published up to March 19, 2021, which suggested the relationship between eHealth literacy and health-related behaviors. Studies were eligible if they were conducted with the general population, presented eHealth literacy according to validated tools, used no specific control condition, and measured health-related behaviors as the outcomes. A meta-analysis was performed on the studies that could be quantitatively synthesized using a random effect model. A pooled correlation coefficient was generated by integrating the correlation coefficients, and the risk of bias was assessed using the modified Newcastle-Ottawa Scale. Among 1922 eHealth literacy-related papers, 29 studies suggesting an association between eHealth literacy and health-related behaviors were included. All retrieved studies were cross-sectional studies, and most of them used the eHealth Literacy Scale (eHEALS) as a measurement tool for eHealth literacy. Of the 29 studies, 22 presented positive associations between eHealth literacy and health-related behaviors. The meta-analysis was performed on 14 studies that presented the correlation coefficient for the relationship between eHealth literacy and health-related behaviors. When the meta-analysis was conducted by age, morbidity status, and type of health-related behavior, the pooled correlation coefficients were 0.37 (95% CI 0.29-0.44) for older adults (aged ≥65 years), 0.28 (95% CI 0.17-0.39) for individuals with diseases, and 0.36 (95% CI 0.27-0.41) for health-promoting behavior. The overall estimate of the correlation between eHealth literacy and health-related behaviors was 0.31 (95% CI 0.25-0.34), which indicated a moderate correlation between eHealth literacy and health-related behaviors. Our results of a positive correlation between eHealth literacy and health-related behaviors indicate that eHealth literacy can be a mediator in the process by which health-related information leads to changes in health-related behaviors. Larger-scale studies with stronger validity are needed to evaluate the detailed relationship between the proficiency level of eHealth literacy and health-related behaviors for health promotion in the future.
Linkhttp://doi.org/10.2196/40778
TitleTelepharmacy Services: Present Status and Future Perspectives: A Review.
AuthorsBaldoni, S; Amenta, F; Ricci, G
JournalMedicina (Kaunas, Lithuania)
Publication Date1 Jul 2019
Date Added to PubMed4 Jul 2019
AbstractBackground and Objectives: The term "telepharmacy" indicates a form of pharmaceutical care in which pharmacists and patients are not in the same place and can interact using information and communication technology (ICT) facilities. Telepharmacy has been adopted to provide pharmaceutical services to underserved areas and to address the problem of pharmacist shortage. This paper has reviewed the multi-faceted phenomenon of telepharmacy, summarizing different experiences in the area. Advantages and limitations of telepharmacy are discussed as well. Materials and Methods: A literature analysis was carried out on PubMed, using as entry term "telepharmacy" and including articles on the topic published between 2012 and 2018. Results: The studies reviewed were divided into three categories of pharmacy practice, namely (1) support to clinical services, (2) remote education and handling of "special pharmacies", and (3) prescription and reconciliation of drug therapies. In general, different telepharmacy services were effective and accompanied by a satisfaction of their targets. Conclusions: Nowadays, the shortage of health personnel, and in particular pharmacists, is a challenging issue that the health systems have to face. The use of a new technology such as telepharmacy can represent a possible option to solve these problems. However, there are unsolved limitations (e.g., legal implications) that make greater diffusion of telepharmacy difficult. Stronger data on the effectiveness of this area of pharmacy care, together with a critical evaluation of its limits, can make actors involved aware about the potentialities of it and could contribute to a larger diffusion of telepharmacy services in the interest of communities and citizens.
Linkhttp://doi.org/10.3390/medicina55070327
TitleeHealth and mHealth.
AuthorsMoss, RJ; Süle, A; Kohl, S
JournalEuropean journal of hospital pharmacy : science and practice
Publication Date1 Jan 2019
Date Added to PubMed4 Jun 2019
AbstractBoth electronic health (eHealth) and mobile health (mHealth) are becoming prominent components of healthcare. In order for healthcare electronic services to be safe and effective and add genuine value to the system, the European Association of Hospital Pharmacists (EAHP) believes that these should be developed in close collaboration with healthcare professionals including hospital pharmacists, and patients. Consequently, the EAHP calls in its position paper upon national governments and health systems across Europe to work towards (1) systematic and European Union-wide achievement of electronic prescribing, administration and use of electronic medical records; (2) ensuring barcoding of medicines to the single units in primary packages to enable more widespread take-up of bedside scanning in European hospitals, thus improving patient safety; (3) appropriate regulatory oversight mechanisms for mHealth applications to ensure that they have a positive impact and adequately protect patient data; (4) provision of appropriate eHealth/mHealth training opportunities to healthcare professionals and promotion of digital health literacy; and (5) involvement of hospital pharmacists in the design, specification of parameters and evaluation of information and communication technology within the medicines processes.
Linkhttp://doi.org/10.1136/ejhpharm-2018-001819
TitlePatient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report.
AuthorsBousquet, J; Shamji, MH; Anto, JM; Schünemann, HJ; Canonica, GW; Jutel, M; Del Giacco, S; Zuberbier, T; Pfaar, O; Fonseca, JA; Sousa-Pinto, B; Klimek, L; Czarlewski, W; Bedbrook, A; Amaral, R; Ansotegui, IJ; Bosnic-Anticevich, S; Braido, F; Chaves Loureiro, C; Gemicioglu, B; Haahtela, T; Kulus, M; Kuna, P; Kupczyk, M; Matricardi, PM; Regateiro, FS; Samolinski, B; Sofiev, M; Toppila-Salmi, S; Valiulis, A; Ventura, MT; Barbara, C; Bergmann, KC; Bewick, M; Blain, H; Bonini, M; Boulet, LP; Bourret, R; Brusselle, G; Brussino, L; Buhl, R; Cardona, V; Casale, T; Cecchi, L; Charpin, D; Cherrez-Ojeda, I; Chu, DK; Cingi, C; Costa, EM; Cruz, AA; Devillier, P; Dramburg, S; Fokkens, WJ; Gotua, M; Heffler, E; Ispayeva, Z; Ivancevich, JC; Joos, G; Kaidashev, I; Kraxner, H; Kvedariene, V; Larenas-Linnemann, DE; Laune, D; Lourenço, O; Louis, R; Makela, M; Makris, M; Maurer, M; Melén, E; Micheli, Y; Morais-Almeida, M; Mullol, J; Niedoszytko, M; O'Hehir, R; Okamoto, Y; Olze, H; Papadopoulos, NG; Papi, A; Patella, V; Pétré, B; Pham-Thi, N; Puggioni, F; Quirce, S; Roche, N; Rouadi, PW; Sá-Sousa, A; Sagara, H; Sastre, J; Scichilone, N; Sheikh, A; Sova, M; Suppli Ulrik, C; Taborda-Barata, L; Todo-Bom, A; Torres, MJ; Tsiligianni, I; Usmani, OS; Valovirta, E; Vasankari, T; Vieira, RJ; Wallace, D; Waserman, S; Zidarn, M; Yorgancioglu, A; Zhang, L; Chivato, T; Ollert, M
JournalAllergy
Publication Date1 Jul 2023
Date Added to PubMed13 Apr 2023
AbstractBiomarkers for the diagnosis, treatment and follow-up of patients with rhinitis and/or asthma are urgently needed. Although some biologic biomarkers exist in specialist care for asthma, they cannot be largely used in primary care. There are no validated biomarkers in rhinitis or allergen immunotherapy (AIT) that can be used in clinical practice. The digital transformation of health and health care (including mHealth) places the patient at the center of the health system and is likely to optimize the practice of allergy. Allergic Rhinitis and its Impact on Asthma (ARIA) and EAACI (European Academy of Allergy and Clinical Immunology) developed a Task Force aimed at proposing patient-reported outcome measures (PROMs) as digital biomarkers that can be easily used for different purposes in rhinitis and asthma. It first defined control digital biomarkers that should make a bridge between clinical practice, randomized controlled trials, observational real-life studies and allergen challenges. Using the MASK-air app as a model, a daily electronic combined symptom-medication score for allergic diseases (CSMS) or for asthma (e-DASTHMA), combined with a monthly control questionnaire, was embedded in a strategy similar to the diabetes approach for disease control. To mimic real-life, it secondly proposed quality-of-life digital biomarkers including daily EQ-5D visual analogue scales and the bi-weekly RhinAsthma Patient Perspective (RAAP). The potential implications for the management of allergic respiratory diseases were proposed.
Linkhttp://doi.org/10.1111/all.15740
TitleMobile Health Apps to Facilitate Self-Care: A Qualitative Study of User Experiences.
AuthorsAnderson, K; Burford, O; Emmerton, L
JournalPloS one
Publication Date1 Dec 2016
Date Added to PubMed24 May 2016
AbstractConsumers are living longer, creating more pressure on the health system and increasing their requirement for self-care of chronic conditions. Despite rapidly-increasing numbers of mobile health applications ('apps') for consumers' self-care, there is a paucity of research into consumer engagement with electronic self-monitoring. This paper presents a qualitative exploration of how health consumers use apps for health monitoring, their perceived benefits from use of health apps, and suggestions for improvement of health apps. 'Health app' was defined as any commercially-available health or fitness app with capacity for self-monitoring. English-speaking consumers aged 18 years and older using any health app for self-monitoring were recruited for interview from the metropolitan area of Perth, Australia. The semi-structured interview guide comprised questions based on the Technology Acceptance Model, Health Information Technology Acceptance Model, and the Mobile Application Rating Scale, and is the only study to do so. These models also facilitated deductive thematic analysis of interview transcripts. Implicit and explicit responses not aligned to these models were analyzed inductively. Twenty-two consumers (15 female, seven male) participated, 13 of whom were aged 26-35 years. Eighteen participants reported on apps used on iPhones. Apps were used to monitor diabetes, asthma, depression, celiac disease, blood pressure, chronic migraine, pain management, menstrual cycle irregularity, and fitness. Most were used approximately weekly for several minutes per session, and prior to meeting initial milestones, with significantly decreased usage thereafter. Deductive and inductive thematic analysis reduced the data to four dominant themes: engagement in use of the app; technical functionality of the app; ease of use and design features; and management of consumers' data. The semi-structured interviews provided insight into usage, benefits and challenges of health monitoring using apps. Understanding the range of consumer experiences and expectations can inform design of health apps to encourage persistence in self-monitoring.
Linkhttp://doi.org/10.1371/journal.pone.0156164
TitleThe Cost-Effectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic Review.
AuthorsJiang, X; Ming, WK; You, JH
JournalJournal of medical Internet research
Publication Date17 Jun 2019
Date Added to PubMed19 Jun 2019
AbstractWith the advancement in information technology and mobile internet, digital health interventions (DHIs) are improving the care of cardiovascular diseases (CVDs). The impact of DHIs on cost-effective management of CVDs has been examined using the decision analytic model-based health technology assessment approach. The aim of this study was to perform a systematic review of the decision analytic model-based studies evaluating the cost-effectiveness of DHIs on the management of CVDs. A literature review was conducted in Medline, Embase, Cumulative Index to Nursing and Allied Health Literature Complete, PsycINFO, Scopus, Web of Science, Center for Review and Dissemination, and Institute for IEEE Xplore between 2001 and 2018. Studies were included if the following criteria were met: (1) English articles, (2) DHIs that promoted or delivered clinical interventions and had an impact on patients' cardiovascular conditions, (3) studies that were modeling works with health economic outcomes of DHIs for CVDs, (4) studies that had a comparative group for assessment, and (5) full economic evaluations including a cost-effectiveness analysis, cost-utility analysis, cost-benefit analysis, and cost-consequence analysis. The primary outcome collected was the cost-effectiveness of the DHIs, presented by incremental cost per additional quality-adjusted life year (QALY). The quality of each included study was evaluated using the Consolidated Health Economic Evaluation Reporting Standards. A total of 14 studies met the defined criteria and were included in the review. Among the included studies, heart failure (7/14, 50%) and stroke (4/14, 29%) were two of the most frequent CVDs that were managed by DHIs. A total of 9 (64%) studies were published between 2015 and 2018 and 5 (36%) published between 2011 and 2014. The time horizon was ≤1 year in 3 studies (21%), >1 year in 10 studies (71%), and 1 study (7%) did not declare the time frame. The types of devices or technologies used to deliver the health interventions were short message service (1/14, 7%), telephone support (1/14, 7%), mobile app (1/14, 7%), video conferencing system (5/14, 36%), digital transmission of physiologic data (telemonitoring; 5/14, 36%), and wearable medical device (1/14, 7%). The DHIs gained higher QALYs with cost saving in 43% (6/14) of studies and gained QALYs at a higher cost at acceptable incremental cost-effectiveness ratio (ICER) in 57% (8/14) of studies. The studies were classified as excellent (0/14, 0%), good (9/14, 64%), moderate (4/14, 29%), and low (1/14, 7%) quality. This study is the first systematic review of decision analytic model-based cost-effectiveness analyses of DHIs in the management of CVDs. Most of the identified studies were published recently, and the majority of the studies were good quality cost-effectiveness analyses with an adequate duration of time frame. All the included studies found the DHIs to be cost-effective.
Linkhttp://doi.org/10.2196/13166
TitleFacilitators and Barriers to Chronic Disease Self-Management and Mobile Health Interventions for People Living With Diabetes and Hypertension in Cambodia: Qualitative Study.
AuthorsSteinman, L; Heang, H; van Pelt, M; Ide, N; Cui, H; Rao, M; LoGerfo, J; Fitzpatrick, A
JournalJMIR mHealth and uHealth
Publication Date24 Apr 2020
Date Added to PubMed25 Apr 2020
AbstractIn many low- and middle-income countries (LMICs), heart disease and stroke are the leading causes of death as cardiovascular risk factors such as diabetes and hypertension rapidly increase. The Cambodian nongovernmental organization, MoPoTsyo, trains local residents with diabetes to be peer educators (PEs) to deliver chronic disease self-management training and medications to 14,000 people with hypertension and/or diabetes in Cambodia. We collaborated with MoPoTsyo to develop a mobile-based messaging intervention (mobile health; mHealth) to link MoPoTsyo's database, PEs, pharmacies, clinics, and people living with diabetes and/or hypertension to improve adherence to evidence-based treatment guidelines. This study aimed to understand the facilitators and barriers to chronic disease management and the acceptability, appropriateness, and feasibility of mHealth to support chronic disease management and strengthen community-clinical linkages to existing services. We conducted an exploratory qualitative study using semistructured interviews and focus groups with PEs and people living with diabetes and/or hypertension. Interviews were recorded and conducted in Khmer script, transcribed and translated into the English language, and uploaded into Atlas.ti for analysis. We used a thematic analysis to identify key facilitators and barriers to disease management and opportunities for mHealth content and format. The information-motivation-behavioral model was used to guide data collection, analysis, and message development. We conducted six focus groups (N=59) and 11 interviews in one urban municipality and five rural operating districts from three provinces in October 2016. PE network participants desired mHealth to address barriers to chronic disease management through reminders about medications, laboratory tests and doctor's consultations, education on how to incorporate self-management into their daily lives, and support for obstacles to disease management. Participants preferred mobile-based voice messages to arrive at dinnertime for improved phone access and family support. They desired voice messages over texts to communicate trust and increase accessibility for persons with limited literacy, vision, and smartphone access. PEs shared similar views and perceived mHealth as acceptable and feasible for supporting their work. We developed 34 educational, supportive, and reminder mHealth messages based on these findings. These mHealth messages are currently being tested in a cluster randomized controlled trial (#1R21TW010160) to improve diabetes and hypertension control in Cambodia. This study has implications for practice and policies in Cambodia and other LMICs and low-resource US settings that are working to engage PEs and build community-clinical linkages to facilitate chronic disease management.
Linkhttp://doi.org/10.2196/13536
TitleImpact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review.
AuthorsNiznik, JD; He, H; Kane-Gill, SL
JournalResearch in social & administrative pharmacy : RSAP
Publication Date1 Aug 2018
Date Added to PubMed5 Nov 2017
AbstractUtilization of telemedicine allows pharmacists to extend the reach of clinical interventions, connecting them with patients and providers, but the overall impact of these services is under-studied. Identify the impact of clinical pharmacist telemedicine interventions on clinical outcomes, subsequently defined as clinical disease management, patient self-management, and adherence, in outpatient or ambulatory settings. A literature search was conducted from database inception through May 2016 in Medline, SCOPUS, and EMBASE. Broad terms "telemedicine", "telehealth", and "telephone" were used in combination with "pharmacist" or "pharmacy" and "telepharmacy". The search and extraction process followed PRISMA guidelines. Results were screened for pharmacist interventions and reviewed to identify studies in outpatient our ambulatory settings. Studies of non-clinical outcomes (i.e. dispensing or product preparation) and with no comparator were excluded. The final studies were categorized by types of outcomes reported: clinical disease management, patient self-management, and adherence. Only 34 studies measured clinical outcomes against a comparator, consistent with the research question. The majority utilized scheduled models of care (n = 29). Telephone was the most common communication method (n = 25). The most utilized interventions were pharmacist-led telephonic clinics (n = 10). Most studies focused on chronic disease management in adults including hypertension, diabetes, anticoagulation, depression, hyperlipidemia, asthma, heart failure, HIV, PTSD, CKD, stroke, COPD and smoking cessation. Twenty-three studies had a positive impact with one reporting negative results. Higher positive impact rate was observed for scheduled (72.4%, 21/29) and continuous (100%, 2/2) models compared to responsive/reactive (25%, 1/4). Clinical pharmacy telemedicine interventions in the outpatient or ambulatory setting, primarily via phone, have an overall positive impact on outcomes related to clinical disease management, patient self-management, and adherence in the management of chronic diseases. Commonalities among studies with positive impact included utilization of continuous or scheduled models via telephone, with frequent monitoring and interventions. Studies identified did not evaluate benefits of video capability over telephone or cost-effectiveness, both of which are useful directions for future study.
Linkhttp://doi.org/10.1016/j.sapharm.2017.10.011
TitleAllergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.
AuthorsBousquet, J; Hellings, PW; Agache, I; Amat, F; Annesi-Maesano, I; Ansotegui, IJ; Anto, JM; Bachert, C; Bateman, ED; Bedbrook, A; Bennoor, K; Bewick, M; Bindslev-Jensen, C; Bosnic-Anticevich, S; Bosse, I; Brozek, J; Brussino, L; Canonica, GW; Cardona, V; Casale, T; Cepeda Sarabia, AM; Chavannes, NH; Cecchi, L; Correia de Sousa, J; Costa, E; Cruz, AA; Czarlewski, W; De Carlo, G; De Feo, G; Demoly, P; Devillier, P; Dykewicz, MS; El-Gamal, Y; Eller, EE; Fonseca, JA; Fontaine, JF; Fokkens, WJ; Guzmán, MA; Haahtela, T; Illario, M; Ivancevich, JC; Just, J; Kaidashev, I; Khaitov, M; Kalayci, O; Keil, T; Klimek, L; Kowalski, ML; Kuna, P; Kvedariene, V; Larenas-Linnemann, D; Laune, D; Le, LTT; Carlsen, KL; Lourenço, O; Mahboub, B; Mair, A; Menditto, E; Milenkovic, B; Morais-Almeida, M; Mösges, R; Mullol, J; Murray, R; Naclerio, R; Namazova-Baranova, L; Novellino, E; O'Hehir, RE; Ohta, K; Okamoto, Y; Okubo, K; Onorato, GL; Palkonen, S; Panzner, P; Papadopoulos, NG; Park, HS; Paulino, E; Pawankar, R; Pfaar, O; Plavec, D; Popov, TA; Potter, P; Prokopakis, EP; Rottem, M; Ryan, D; Salimäki, J; Samolinski, B; Sanchez-Borges, M; Schunemann, HJ; Sheikh, A; Sisul, JC; Rajabian-Söderlund, R; Sooronbaev, T; Stellato, C; To, T; Todo-Bom, AM; Tomazic, PV; Toppila-Salmi, S; Valero, A; Valiulis, A; Valovirta, E; Ventura, MT; Wagenmann, M; Wang, Y; Wallace, D; Waserman, S; Wickman, M; Yorgancioglu, A; Zhang, L; Zhong, N; Zidarn, M; Zuberbier, T; Bousquet, J; Hellings, PW; Aberer, W; Agache, I; Akdis, CA; Akdis, M; Alberti, MR; Almeida, R; Amat, F; Angles, R; Annesi-Maesano, I; Ansotegui, IJ; Anto, JM; Arnavielle, S; Asayag, E; Asarnoj, A; Arshad, H; Avolio, F; Bacci, E; Bachert, C; Baiardini, I; Barbara, C; Barbagallo, M; Baroni, I; Barreto, BA; Basagana, X; Bateman, ED; Bedolla-Barajas, M; Bedbrook, A; Bewick, M; Beghé, B; Bel, EH; Bergmann, KC; Bennoor, KS; Benson, M; Bertorello, L; Białoszewski, AZ; Bieber, T; Bialek, S; Bindslev-Jensen, C; Bjermer, L; Blain, H; Blasi, F; Blua, A; Bochenska Marciniak, M; Bogus-Buczynska, I; Boner, AL; Bonini, M; Bonini, S; Bosnic-Anticevich, CS; Bosse, I; Bouchard, J; Boulet, LP; Bourret, R; Bousquet, PJ; Braido, F; Briedis, V; Brightling, CE; Brozek, J; Bucca, C; Buhl, R; Buonaiuto, R; Panaitescu, C; Burguete Cabañas, MT; Burte, E; Bush, A; Caballero-Fonseca, F; Caillot, D; Caimmi, D; Calderon, MA; Camargos, PAM; Camuzat, T; Canfora, G; Canonica, GW; Cardona, V; Carlsen, KH; Carreiro-Martins, P; Carriazo, AM; Carr, W; Cartier, C; Casale, T; Castellano, G; Cecchi, L; Cepeda Sarabia, AM; Chavannes, NH; Chen, Y; Chiron, R; Chivato, T; Chkhartishvili, E; Chuchalin, AG; Chung, KF; Ciaravolo, MM; Ciceran, A; Cingi, C; Ciprandi, G; Carvalho Coehlo, AC; Colas, L; Colgan, E; Coll, J; Conforti, D; Correia de Sousa, J; Cortés-Grimaldo, RM; Corti, F; Costa, E; Costa-Dominguez, MC; Courbis, AL; Cox, L; Crescenzo, M; Cruz, AA; Custovic, A; Czarlewski, W; Dahlen, SE; Dario, C; da Silva, J; Dauvilliers, Y; Darsow, U; De Blay, F; De Carlo, G; Dedeu, T; de Fátima Emerson, M; De Feo, G; De Vries, G; De Martino, B; de Paula Motta Rubini, N; Deleanu, D; Demoly, P; Denburg, JA; Devillier, P; Di Capua Ercolano, S; Di Carluccio, N; Didier, A; Dokic, D; Dominguez-Silva, MG; Douagui, H; Dray, G; Dubakiene, R; Durham, SR; Du Toit, G; Dykewicz, MS; El-Gamal, Y; Eklund, P; Eller, E; Emuzyte, R; Farrell, J; Farsi, A; Ferreira de Mello, J; Ferrero, J; Fink-Wagner, A; Fiocchi, A; Fokkens, WJ; Fonseca, JA; Fontaine, JF; Forti, S; Fuentes-Perez, JM; Gálvez-Romero, JL; Gamkrelidze, A; Garcia-Aymerich, J; García-Cobas, CY; Garcia-Cruz, MH; Gemicioğlu, B; Genova, S; George, C; Gereda, JE; Gerth van Wijk, R; Gomez, RM; Gómez-Vera, J; González Diaz, S; Gotua, M; Grisle, I; Guidacci, M; Guldemond, NA; Gutter, Z; Guzmán, MA; Haahtela, T; Hajjam, J; Hernández, L; Hourihane, JO'; Huerta-Villalobos, YR; Humbert, M; Iaccarino, G; Illario, M; Ivancevich, JC; Jares, EJ; Jassem, E; Johnston, SL; Joos, G; Jung, KS; Jutel, M; Kaidashev, I; Kalayci, O; Kalyoncu, AF; Karjalainen, J; Kardas, P; Keil, T; Keith, PK; Khaitov, M; Khaltaev, N; Kleine-Tebbe, J; Klimek, L; Kowalski, ML; Kuitunen, M; Kull, I; Kuna, P; Kupczyk, M; Kvedariene, V; Krzych-Fałta, E; Lacwik, P; Larenas-Linnemann, D; Laune, D; Lauri, D; Lavrut, J; Le, LTT; Lessa, M; Levato, G; Li, J; Lieberman, P; Lipiec, A; Lipworth, B; Lodrup Carlsen, KC; Louis, R; Lourenço, O; Luna-Pech, JA; Maciej, K; Magnan, A; Mahboub, B; Maier, D; Mair, A; Majer, I; Malva, J; Mandajieva, E; Manning, P; De Manuel Keenoy, E; Marshall, GD; Masjedi, MR; Maspero, JF; Mathieu-Dupas, E; Matta Campos, JJ; Matos, AL; Maurer, M; Mavale-Manuel, S; Mayora, O; Medina-Avalos, MA; Melén, E; Melo-Gomes, E; Meltzer, EO; Menditto, E; Mercier, J; Miculinic, N; Mihaltan, F; Milenkovic, B; Moda, G; Mogica-Martinez, MD; Mohammad, Y; Momas, I; Montefort, S; Monti, R; Mora Bogado, D; Morais-Almeida, M; Morato-Castro, FF; Mösges, R; Mota-Pinto, A; Moura Santo, P; Mullol, J; Münter, L; Muraro, A; Murray, R; Naclerio, R; Nadif, R; Nalin, M; Napoli, L; Namazova-Baranova, L; Neffen, H; Niedeberger, V; Nekam, K; Neou, A; Nieto, A; Nogueira-Silva, L; Nogues, M; Novellino, E; Nyembue, TD; O'Hehir, RE; Odzhakova, C; Ohta, K; Okamoto, Y; Okubo, K; Onorato, GL; Ortega Cisneros, M; Ouedraogo, S; Pali-Schöll, I; Palkonen, S; Panzner, P; Papadopoulos, NG; Park, HS; Papi, A; Passalacqua, G; Paulino, E; Pawankar, R; Pedersen, S; Pépin, JL; Pereira, AM; Persico, M; Pfaar, O; Phillips, J; Picard, R; Pigearias, B; Pin, I; Pitsios, C; Plavec, D; Pohl, W; Popov, TA; Portejoie, F; Potter, P; Pozzi, AC; Price, D; Prokopakis, EP; Puy, R; Pugin, B; Pulido Ross, RE; Przemecka, M; Rabe, KF; Raciborski, F; Rajabian-Soderlund, R; Reitsma, S; Ribeirinho, I; Rimmer, J; Rivero-Yeverino, D; Rizzo, JA; Rizzo, MC; Robalo-Cordeiro, C; Rodenas, F; Rodo, X; Rodriguez Gonzalez, M; Rodriguez-Mañas, L; Rolland, C; Rodrigues Valle, S; Roman Rodriguez, M; Romano, A; Rodriguez-Zagal, E; Rolla, G; Roller-Wirnsberger, RE; Romano, M; Rosado-Pinto, J; Rosario, N; Rottem, M; Ryan, D; Sagara, H; Salimäki, J; Samolinski, B; Sanchez-Borges, M; Sastre-Dominguez, J; Scadding, GK; Schunemann, HJ; Scichilone, N; Schmid-Grendelmeier, P; Serpa, FS; Shamai, S; Sheikh, A; Sierra, M; Simons, FER; Siroux, V; Sisul, JC; Skrindo, I; Solé, D; Somekh, D; Sondermann, M; Sooronbaev, T; Sova, M; Sorensen, M; Sorlini, M; Spranger, O; Stellato, C; Stelmach, R; Stukas, R; Sunyer, J; Strozek, J; Szylling, A; Tebyriçá, JN; Thibaudon, M; To, T; Todo-Bom, A; Tomazic, PV; Toppila-Salmi, S; Trama, U; Triggiani, M; Suppli Ulrik, C; Urrutia-Pereira, M; Valenta, R; Valero, A; Valiulis, A; Valovirta, E; van Eerd, M; van Ganse, E; van Hague, M; Vandenplas, O; Ventura, MT; Vezzani, G; Vasankari, T; Vatrella, A; Verissimo, MT; Viart, F; Viegi, M; Vicheva, D; Vontetsianos, T; Wagenmann, M; Walker, S; Wallace, D; Wang, DY; Waserman, S; Werfel, T; Westman, M; Wickman, M; Williams, DM; Williams, S; Wilson, N; Wright, J; Wroczynski, P; Yakovliev, P; Yawn, BP; Yiallouros, PK; Yorgancioglu, A; Yusuf, OM; Zar, HJ; Zhang, L; Zhong, N; Zernotti, ME; Zidarn, M; Zuberbier, T; Zubrinich, C; Zurkuhlen, A
JournalThe Journal of allergy and clinical immunology
Publication Date1 Mar 2019
Date Added to PubMed3 Oct 2018
AbstractAllergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-based tools (Mobile Airways Sentinel Network [MASK]) that can inform patient decisions on the basis of a self-care plan proposed by the health care professional.
Linkhttp://doi.org/10.1016/j.jaci.2018.08.049
MNCHFPRHHIV/AIDSMalariaNoncommunicable diseaseCOVID-19Decision-makingEducation & trainingBehavior changeGovernancePrivacy & securityEquityCHWsYouth & adolescentsSystematic reviewsProtocols & research designMedical RecordsLaboratoryPharmacyHuman ResourcesmHealthSMSChatbotsAI